In recent years, the development of the pharmaceutical industry in Kyrgyzstan has become increasingly important. Japan, known for its high standards in science and technology, has confirmed its participation and financial support for the second stage of construction and development of the new Dordoi Dary pharmacology building. This project is aimed at creating a modern pharmaceutical production facility that can provide both the domestic market and export opportunities.

The pharmaceutical sector is one of the key sectors in the economy of any country, and Kyrgyzstan is no exception. The growing demand for high-quality medicines and medical products leads to the need to create modern production facilities that can meet these needs. The creation of the new Dordoi Dary building involves the introduction of advanced technologies and German equipment, which will significantly improve the quality and safety of the drugs produced.

Japan’s financial support is associated not only with economic interests, but also with a long-term strategy for cooperation between the two countries in science and technology.

In addition, the implementation of the Dordoi Dary project opens up new horizons for international cooperation. Kyrgyzstan will be able to offer its products on foreign markets, which will be an important step towards integration into the global economy. Japanese pharmaceutical companies may consider opportunities for joint business initiatives, including technology exchange and joint research.

The second stage of construction is not limited to the construction of new facilities. It includes the creation of innovative infrastructure, the development of new drugs and the implementation of a quality control system that meets international standards. Partnership with Japanese companies will allow Kyrgyz pharmacists to use experience and best practices, which in turn will increase the competitiveness of products. It is important to note that Japan’s support will also be aimed at environmental aspects of production. One of the project’s priorities will be the use of sustainable and safe technologies, which is in line with global trends in environmental protection. This approach will not only improve the image of the pharmaceutical industry in Kyrgyzstan, but also ensure safety for the population and nature.